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 Rabies is an acute viral infection of the central nervous system, caused by a 
lyssavirus in the family Rhabdoviridae. It is zoonotic viral disease that can 
affect all mammals, including humans, cats, dogs, and wildlife and farm 
animals. The virus is present in the saliva of affected animals, and the most 
frequent method of transmission to humans is by bites, scratches or licks to 
broken skin or mucous membranes. The disease has a long incubation period 
(six months) and symptoms may take several weeks to appear after infection. 
The first clinical symptom is neuropathic pain at the site of infection or 
wound due to viral replication. Diagnosis can only be confirmed by 
laboratory tests preferably conducted post mortem on central nervous system 
tissue removed from cranium. This paper reviews the possible prevention and 
control of rabies. Essential components of rabies prevention and control 
include ongoing public education, responsible pet ownership, routine 
veterinary care and vaccination, and professional continuing education.  
Control strategies include quarantine, confirmation of diagnosis, determining 
the origin and spread of an outbreak. Since rabies is invariably fatal and 
deadly viral disease that can only be prevented the collaborative effort 
between Veterinarians and human health care professionals are needed in the 
prevention and control of rabies. 
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1. INTRODUCTION 
Rabies is a viral disease that affects the central nervous system of warm-blooded animals, including 
humans [1],[2] and it is a zoonotic viral disease that produces almost invariably fatal encephalitis in humans 
and most other mammals [3]. The disease is characterized by the development of severe nervous symptoms 
that lead to paralysis and death [4]. Once symptoms of the disease develop, it is invariably fatal and deadly 
viral disease that can only be prevented but not cured [5]. Dogs remain the primary reservoir in developing 
countries, whereas wildlife species serve as hosts in developed nations [6]. 
Rabies is widely distributed throughout the world with the exception of Australia, New Zealand, 
Japan, a number of European countries and some Caribbean Islands. Wild animals serve as a large and 
mainly uncontrollable reservoir of sylvatic rabies, which is an increasing threat to the human population and 
to domestic animals in many countries [1]. Rabies is an acute viral infection of the central nervous system, 
caused by a lyssavirus in the family Rhabdoviridae [4],[7].  
The name Rhabdo comes from the Greek and identifies the characteristic bullet or rod-shape of the 
viruses [1]. It affects all mammals, including humans, cats, dogs, wild life and farm animals. In animals, 
three forms are classically described; prodromal, excitement (furious) and paralytic (dumb). The virus is 
present in the saliva of affected animals, and the most frequent method of transmission to humans is by bites, 
scratches or licks to broken skin or mucous membranes [8]. The virus is spread through infected saliva in 
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bites, scratches and through licks from infected animals in open wounds or on mucosal membranes 
[7],[9],[10].   
Rabies infection in humans is still a major public health Problem all over the world [11]. Rabies 
kills an estimated 35,000 per year, mostly in Africa, Asia and Latin America [6]. The World Health 
Organization (WHO) considers rabies to be a neglected disease and declare it to be primarily a problem in 
areas troubled with poverty and with a lack of economic resources [12]. With over 55 000 human deaths a 
year [7] and signs of it re-emerging [9]. The domestic dog is the most important vector of human exposure 
[13]. It is possible to prevent a person exposed to the virus from getting ill to rabies by neutralizing virus with 
antibodies before the virus invades the nervous tissue. This is done through vaccination and/or use of 
immunoglobulins, so called post-exposure prophylaxis (PEP) [7],[14]. Public awareness and an increase of 
knowledge about rabies disease, first aid measures after dog bites, increased knowledge about dog behavior 
and how to avoid getting bitten by dogs are suggested methods to prevent rabies in humans [7],[9]. Therefore 
the main objective of this paper is to review the current information available for prevention and control of 
rabies. 
 
 
2. LITERATURE REVIEW 
2.1. Etiology 
The causative agent of rabies is a member of the Lyssavirus genus of the Rhabdoviridae family of 
bullet-shaped viruses, which have a single-stranded RNA genome [1],[7]. The genus includes the classical 
rabies virus (genotype 1) and six so-called rabies-related viruses, Lagos bat virus (genotype 2), Mokola virus 
(genotype 3), Duvenhage virus (genotype 4), European bat lyssaviruses 1 and 2 (genotypes 5 and 6), and the 
recently discovered Australian bat genotype 7 [15]. The genus Lyssa virus comprises rabies virus and closely 
related viruses, including Mokola virus,  Lagos bat virus and Duvenhage virus from Africa, European bat 
virus 1 and 2 and Australian bat Lyssavirus. Each of these viruses is considered capable of causing rabies like 
disease in animals and humans [1]. Rabies virus can be inactivated by sodium hypochlorite, 45-75% ethanol, 
iodine preparations, quaternary ammonium compounds, formaldehyde, phenol, ether, trypsin, β-
propiolactone, and some other detergents. It is also inactivated by a very low pH (below 3) or very high pH 
(greater than 11). This virus is susceptible to ultraviolet radiation. It is rapidly inactivated by sunlight and 
drying, and (in dried blood and secretions) it does not survive for long periods in the environment [16]. 
 
2.2. Epidemiology 
2.2.1. geographic distribution 
With some exceptions (particularly islands), rabies virus is found worldwide. Some countries such 
as the United Kingdom, Ireland, Sweden, Norway, Iceland, Japan, Australia, New Zealand, Singapore, most 
of Malaysia, Papua New Guinea, the Pacific Islands and some Indonesian islands have been free of this 
virus for many years [17]. Rabies is a serious disease threat to humans, domestic animals, and wildlife. 
Worldwide rabies kills about 50,000 – 100,000 people/year and countless domestic and wild animals [18]. 
In Europe the red fox is the most important reservoir host and vector of rabies. An increase in incidence of 
rabies in foxes result in an increase in incidence of rabies in domestic animals such as cattle, sheep, horse, 
cat, dog and others. 
Sylvatic and urban rabies cycles occur concurrently in some regions, while the sylvatic cycle 
predominates in others. For example, wild animals accounted for more than 90% of the animal rabies cases 
reported in the U.S. and Canada in 2010. Rabies can be a serious concern in some rare or endangered 
species. In Africa, the Ethiopian wolf (Canis simensis) and African wild dogs (Lycaon pictus) are 
threatened by this virus. Although cases of rabies tend to be sporadic, epizootics are possible [16]. 
 
2.2.2. Host range 
All mammals are susceptible to rabies, but only a limited number of species also act as reservoir 
hosts. They include members of the families Canidae (dogs, jackals, coyotes, wolves, foxes and raccoon 
dogs), Mustelidae (e.g., skunks), Viverridae (e.g., mongooses), and Procyonidae (raccoons), and the order 
Chiroptera (bats) [17]. Rabies reservoirs are generally grouped into terrestrial (i.e., land-dwelling) species 
and bat species. Rabies can occur sporadically in individuals or can exist in an enzootic or epizootic state in 
animal populations. In enzootic state rabies is indigenous to a reservoir species in a locality and occurs with 
a relatively stable incidence rate. An epizootic occurs when the incidence of disease increases markedly in 
the reservoir species. Rabies that is transmitted sporadically from reservoir to non-reservoir species is said 
to “spillover”. These reservoir species are: raccoon (Procyon lotor), striped skunk (Mephitis mephitis), 
coyote (Canis latrans; infected with the dog variant), gray fox (Urocyon cinereoargenteus), and Arctic fox 
(Alopex lagopus) and red fox (Vulpes vulpes) [18]. 
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2.2.3. Transmission 
A rabies exposure is any bite, scratch, or other situation in which saliva, cerebral spinal fluid, tears, 
or nervous tissue from a suspect or known rabid animal or person enters an open wound, is transplanted into, 
or comes in contact with mucous membranes of another animal or person. On rare occasions human rabies 
has been acquired by inhalation of airborne virus in laboratories working with live rabies virus and in caves 
with millions of bats. The common mode of transmission of rabies in man is by bite of a rabid animal or the 
contamination of scratch wounds by virus infected saliva [19]. 
 
2.3. Pathogenesis 
Rabies virus enters the body through wounds or by direct contact with mucosal surfaces. It cannot 
cross intact skin. Rabies virus replicates in the bitten muscle (local viral proliferation in non-neural tissue) 
and gains access (viral attachment) to motor endplates and motor axons to reach the central nervous system 
[20]. Virions are carried in transport vesicles [21] and travel to the central nervous system (CNS) exclusively 
by fast retrograde transport along motor axons, with no uptake by sensory or sympathetic endings [22]. 
Following centrifugal transport along efferent cranial nerves, the salivary glands become infected 
and virus particles are shed in the saliva. Infection of the brain commonly leads to behavioural changes that 
induce the host to bite other animals, thereby transmitting the virus. The widespread central nervous system 
infection almost inevitably leads to death, usually through respiratory paralysis, but also through secondary 
circulatory, metabolic or infectious processes [23],[24]. 
Viruses can also enter motor axons in peripheral nerves directly during a penetrating injury. The 
incubation period varies from 5 days to several years (usually 2–3 months; rarely more than 1 year), 
depending on the amount of virus in the inoculum, the density of motor endplates at the wound site and the 
proximity of virus entry to the central nervous system [25]. 
The incubation period is less than 50 days if the patient is bitten on the head or neck or if a heavy 
inoculum is transferred through multiple bites, deep wounds, or large wounds. A person with a scratch on the 
hand may take longer to develop symptoms of rabies than a person who receives a bite to the head. In dogs 
and cats, the incubation period is 10 days to 6 months; most cases become apparent between 2 weeks and 3 
months. In cattle, an incubation period from 25 days to more than 5 months has been reported in vampire bat- 
transmitted rabies. In humans, the incubation period can be a few days to several years. Most cases become 
apparent after 1-3 months [17]. 
 
2.4. Clinical signs 
The clinical picture can be highly variable between different species, individuals of the same 
species, and even within the course of the disease in a particular individual. As the disease progresses, 
animals with rabies may show strange behavior. Any clinical suspicion of rabies must be confirmed by 
laboratory examination [5]. 
The initial clinical signs are often nonspecific and may include fearfulness, restlessness, anorexia or 
an increased appetite, vomiting, diarrhea, a slight fever, dilation of the pupils, hyperreactivity to stimuli and 
excessive salivation. The first sign of post-vaccinal rabies is usually lameness in the vaccinated leg. Animals 
often have behavioral and temperament changes, and may become either unusually aggressive or 
uncharacteristically affectionate [17]. 
 
2.4.1. Prodromal stage 
After a certain incubation period, the onset of clinical symptoms follows. During this first stage 
which usually lasts for about 1-3 days minor behavioral changes might occur, i.e. aggressiveness in tame 
animals, daytime activities in nocturnal animals, no fear of humans in wild animals or abnormalities in 
appetite [26]. 
 
2.4.2. Excitement (furious) phase 
Eventually, the prodromal stage is followed by a period of severe agitation and aggressiveness. The 
animal often bites any material. Rabid dogs, for example, may develop a typical high barking sound during 
furious rabies. Death may follow convulsions even without the paralytic stage of the disease [17]. 
The furious form is characterized by restlessness, wandering, howling, polypnea, drooling and 
attacks on other animals, people or inanimate objects. Affected animals often swallow foreign objects such as 
sticks and stones. Wild animals frequently lose their fear of humans, and may attack humans or animal 
species they would normally avoid (e.g., porcupines). Nocturnal animals may be visible during the day. In 
cattle, unusual alertness can also be a sign of this form [17]. 
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2.4.3. Paralytic (dumb) phase 
The “dumb” form of rabies is characterized by progressive paralysis. In this form, the throat and 
masseter muscles become paralyzed; the animal may be unable to swallow, and it can salivate profusely. 
Laryngeal paralysis can cause a change in vocalization, including an abnormal bellow in cattle or a hoarse 
howling in dogs. There may also be facial paralysis or the lower jaw may drop. Ruminants may separate from 
the herd and can become somnolent or depressed. Rumination may stop. Ataxia, incoordination and 
ascending spinal paresis or paralysis are also seen [17]. This stage is characterized by the inability to 
swallow, leading to a typical sign of foaming saliva around the mouth. Some animals may develop paralysis 
beginning at the hind extremities. Eventually, complete paralysis is followed by death [26]. 
 
2.5. Diagnosis 
Laboratory diagnosis of rabies in humans and animals is essential for timely post-exposure 
prophylaxis. Rabies diagnosis may be carried out either in vivo or postmortem [27]. Infection with rabies 
virus can be difficult to diagnose ante-mortem. Although hydrophobia is highly suggestive, no clinical signs 
of disease are pathognomonic for rabies. Historical reliance on the detection of accumulations of Negri-
bodies is no longer regarded as suitable for diagnostic assessment because of low sensitivity and alternative 
laboratory-based tests based have been developed to conclusively confirm infection [4]. 
Most diagnostic tests for rabies virus in animals need brain material for diagnosis and as such are 
often only possible post mortem [28]. The diagnosis of rabies in animals can be made by taking any part from 
the affected brain. But in order to rule out rabies, the test must include tissues from at least two locations in 
brain, from the brain stem and cerebellum. There are many diagnosis methods for detection of rabies in 
animals like (Table 1); direct florescent antibody, mouse inoculation technique, tissue culture infection 
technique, and polymerase chain reaction [29]. Brain samples are most readily taken by breaching the skull 
and sampling directly. Brain smears or touch impressions are used for the meni detection of virus antigen 
with the fluorescent antibodytest (FAT) for both human and animal samples. In animals the direct fluorescent 
antibody test (dFAT) is the recommended diagnostic test. This test detects the presence of rabies antigens in 
brain tissue. Other diagnostic techniques include reverse transcription polymerase chain reaction (RT-PCR), 
direct rapid neur immunohistochemistry test (dRIT) and serological tests (Fluorescent antibody neutralization 
test, rapid pres fluorescent focus inhibition test). In humans, the rabies recommended test is dFAT on brain 
tissue. Other diagnostic tests that have been used are RT-PCR and dRIT [4]. 
Clinical diagnosis of rabies divided upon three stages in human; prodromal, excitement (furious) and 
paralytic (dumb). But all these stages cannot be observed in an individual. The very first clinical symptom is 
neuropathic pain at the site of infection or wound due to viral replication. Following by the prodromal phase 
either or both the excitement or paralytic forms of the disease may be observed in the particular species. It is 
also documented that cats are more likely to develop furious rabies than dogs [29]. In some cases, no signs 
are observed and rabies virus has been identified as the case of sudden death [30]. Diagnosis can only be 
confirmed by laboratory tests preferably conducted post mortem on central nervous system tissue removed 
from cranium [31].  
Rabies must be considered in the differential diagnosis of any suspected mammalian meningitis/ 
encephalitis, distemper, infectious canine hepatitis and cerebral cysticercosis (Taenia solium) in dogs, 
sporadic bovine encephalomyelitis (Chlamydia psittaci), heartwater in cattle and sheep. Other conditions like 
mineral/ pesticide poisoning and Plant poisoning from Pennisetum clandestinum (kikuyu grass) in cattle, 
Cynanchum spp (monkey rope) in sheep should be considered [23]. 
 
 
Table 1. Diagnostic Techniques for Rabies 
Source: (Yousaf et al., 2012) [29] 
 
 
 
Technique Specimen Advantage/Disadvantage 
Direct Fluorescent Antibody 
Technique (DFA) 
Target organs, such as brain, salivary glands, 
liver, spleen, pancreas, nuchal skin, brain is the 
most appropriate sample 
Applicable with most tissue sources. Not 
applicable in decomposed tissue 
Mouse Inoculation 
Technique (MIT) 
Similar to DFA Only use fresh tissues 
Tissue Culture Infection 
technique (TCIT) 
Similar to DFA Only use fresh tissues 
Polymerase Chain Reaction 
(PCR) 
Similar to DFA including body fluids, saliva, 
urine, CSF 
Applicable in all tissue conditions 
Expensive 
Need experienced technicians 
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2.6. Prevention and control 
There is no certain cure for rabies except supportive care. Rabies can be prevented before the latent 
symptoms can develop, consists of giving a person an injection of rabies immune globulin and another 
injection of rabies vaccine as soon as possible after the bite or exposure to saliva from an infected animal 
[29]. 
 
2.6.1. Principles of rabies prevention and control 
2.6.1.1. Case definition 
An animal is determined to be rabid after diagnosis by a qualified laboratory and confirmation either 
by a positive direct fluorescent antibody test (preferably performed on central nervous system tissue) or 
Isolation of rabies virus in cell culture or in a laboratory animal. 
 
2.6.1.2. Rabies exposure 
Rabies is transmitted when the virus is introduced into bite wounds, open cuts in skin, or onto 
mucous membranes from saliva or other potentially infectious material such as neural tissue [32]. 
 
2.6.1.3. Public health education 
Essential components of rabies prevention and control include ongoing public education, responsible 
pet ownership, routine veterinary care and vaccination, and professional continuing education. The majority 
of animal and human exposures to rabies can be prevented by raising awareness concerning: rabies 
transmission routes, and avoiding contact with wildlife. Prompt recognition and reporting of possible 
exposures to medical professionals and local public health authorities is critical [32]. 
 
2.6.1.4. Human rabies prevention 
Human rabies can be prevented by a) eliminating exposure to rabies virus, b) providing appropriate 
rabies pre-exposure prophylaxis, and c) prompt local treatment of bite wounds combined with appropriate 
rabies post-exposure prophylaxis [32]. Inactivated human vaccines are available for at risk veterinary staff, 
other animal handlers, wildlife officers, laboratory workers and others at high risk of exposure. 
 
2.6.1.5. Mestic animal rabies control 
The primary components of a rabies control program for companion animals are: immunization and 
licensing; stray animal control; reporting, investigation, and isolation of animals involved in bite incidents; 
and public education. Multiple vaccines are licensed for use in domestic animal species. Vaccines available 
include: inactivated or modified live virus vectored products; products for intramuscular and subcutaneous 
administration; products with durations of immunity from one to 4 years; and products with varying 
minimum age of vaccination [32]. 
 
2.6.1.6. Animal bites reporting 
The local health officer or designee shall be immediately notified of any person or animal bitten by 
or potentially exposed to a rabid or suspected rabid animal. In addition, the local health officer or designee 
shall be notified when any person is bitten by a mammal. Potential human rabies exposures are then 
evaluated and rabies post-exposure prophylaxis (PEP) recommendations made [32]. 
 
2.6.1.7. Stray animals 
Stray dogs, cats, and ferrets should be removed from the community. Local health departments and 
animal control officials can enforce the removal of strays more effectively if owned animals are required to 
have identification and are confined or kept on leash. Strays should be impounded for at least 3 business days 
to determine if human exposure has occurred and to give owners sufficient time to reclaim animals [33]. 
 
2.6.1.8. Isolation of animals exposed to rabies 
Any animal bitten by, scratched by, or having direct contact with a wild mammal that is not 
available for rabies testing should be regarded as having been exposed to rabies. All livestock species-horses, 
cattle, sheep, goats, llamas/alpacas, and swine are susceptible to rabies infection. Cattle and horses are the 
livestock species most frequently diagnosed with rabies. Unvaccinated livestock bitten by or exposed to a 
rabid or suspect rabid animal should be euthanized [32]. 
 
2.6.1.9. Wild animal rabies control 
Principles of rabies prevention should focus on excluding wild animals from areas of human and 
domestic animal habitation and activity, and avoidance of contact with possibly rabid wild animals. Public 
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education on the risks of rabies transmission from wild animals is paramount to effective disease prevention. 
Immunization of wildlife by widespread distribution of vaccine-impregnated oral baits has shown variable 
success toward arresting the propagation of rabies in raccoons and coyotes in other states. The use of oral 
rabies vaccines (ORV) for the mass vaccination of free-ranging wildlife should be considered in selected 
situations [32]. 
 
2.6.2. Animal pre-exposure vaccination 
A number of recently developed, highly-effective, thermo stable, inactivated vaccines are available 
for veterinary use. The duration of immunity conferred varies from one to three years. Most veterinary 
vaccines are only registered for use in specific species, for example dogs. All rabies vaccines registered for 
human and animal use must conform to established potency standards. A minimum antigenic potency of 2.5 
IU per dose is mandatory [34]. 
The vaccines may be used in young pups, but they must be boosted at three months of age and again 
within the following year. Revaccination must be carried out every three years thereafter. Cattle and sheep 
may be vaccinated annually or every two to three years, depending on the vaccine manufacturer's 
instructions. Following an outbreak in domestic livestock, vaccination of animals without visible bite wounds 
is strongly recommended [35]. 
There are currently 17 parenteral animal rabies vaccines licensed by the U.S. Department of 
Agriculture (USDA) for use in dogs, cats, sheep, cattle, horses, and/or ferrets. Some are approved for dogs or 
cats for a multi-year immunity period and others for only a 1-year period. All dogs and cats should be 
revaccinated 12 months after initial vaccination regardless of the length of immunity period of the initial 
vaccine. Obtaining a booster vaccination immediately following an exposure to a rabid animal is important to 
ensure adequate protection against the virus [35]. 
 
2.6.3. Animal post-exposure treatment 
Findings from a study conducted by Hanlon .et al., 2002 suggested that 5 doses of canine rabies 
vaccine administered on days 0, 3, 14, 21 and 35 along with murine anti-rabies antibody on day 0 may be 
effective in protecting a previously unvaccinated animal exposed to rabies. Regardless of the age of the 
animal at initial vaccination, a booster vaccination should be administered 1 year later [5]. If signs suggestive 
of rabies develop (e.g., paralysis, seizures, etc.), the animal should be euthanized and the head shipped for 
testing [36]. 
 
2.6.4. Outbreak prevention and control 
The emergence of new rabies virus variants or the introduction of non-indigenous viruses poses a 
significant risk to humans, domestic animals, and wildlife [37]. A rapid and comprehensive response includes 
the following measures [38]: 
 Characterize the virus at the national reference laboratory. 
 Identify and control the source of the introduction. 
 Enhance laboratory-based surveillance in wild and domestic animals. 
 Increase animal rabies vaccination rates. 
 Restrict the movement of animals. 
 Evaluate the need for vector population reduction. 
 Coordinate a multiagency response. 
 Provide public and professional outreach and education. 
 
2.6.5. Rabies control strategies 
According to Bishop et al., (2003) Rabies Control Strategies includes quarantine, confirmation of 
diagnosis, determining the origin and spread of an outbreak, and specific measures to terminate 
transmission [23]. It is absolutely essential to confirm the diagnosis of rabies. When an outbreak has 
been confirmed, the responsible state veterinarian decides on the area requiring vaccination. 
 
2.6.5.1. Large-scale vaccination 
Large-Scale Vaccination is the initial response to rabies outbreaks in endemic high-risk areas. The 
aim should be to vaccinate at least 70 % of the animal population at risk in a single campaign within 
as short a period as possible. Where this cannot be achieved, two or more campaigns should be 
conducted within a year. 
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2.6.5.2. Cordon vaccination 
The aim of cordon vaccination is to create a barrier of animal immunity. This approach has 
become increasingly important during the second phase of canine rabies elimination, particularly in the 
vicinity of international borders and national as well as provincial game reserves. This is necessary to 
prevent reinfection of areas currently free from rabies and to protect rabies-free wildlife areas. A cordon of 
20 to 30 km is usually sufficient for this purpose  
 
2.6.5.3. Ring vaccination 
In areas where an isolated case has been diagnosed, ring vaccination with a radius of 20 to 30 
km, where at least 70 % of dogs are vaccinated, has proven successful in controlling or eliminating rabies  
 
2.6.5.4. Door-to-door vaccination 
Vaccination on a home-to-home basis is generally more expensive, resource intensive and 
time consuming, but coverage is invariably better. An example of the success of this approach is 
illustrated by a campaign in Eerstehoek, a rural district in Mpumalanga. In 1998, 20 officials 
vaccinated 6498 dogs in 30 villages extending over 594 km2
 
on a home-to-home basis. All 
vaccinated dogs were identified with neckbands. 
 
2.6.5.5. Central-point vaccination 
These campaigns are usually conducted at least annually in areas where rabies is endemic and the 
prevalence of outbreaks is high. The public are requested to bring their pets to identified venues. 
Accurate epidemiological information, good advertising and adequate planning are of paramount 
importance to ensure high coverage. Results vary from 20 to 80 % and depend on the degree of attention 
to detail. Coverage is generally better if the campaign follows shortly after a well-publicised rabies 
outbreak. 
 
2.6.5.6. Oral vaccination 
Sylvatic rabies has been successfully eradicated in Switzerland and other European countries 
using bait vaccine. A bait containing a live, avirulent rabies virus mutant, SAG2, has been formulated 
specifically for dogs and the first field trials were conducted in South Africa. 
 
 
3. CONCLUSIONS AND RECOMMENDATIONS 
Rabies is a fatal viral zoonotic disease and a serious public health problem. Though its 
occurrence is worldwide, it is important in developing countries like Ethiopia. This is because of 
widespread occurrence of large number of stray dogs. In Africa, the Ethiopian wolf (Canis simensis) and 
African wild dogs (Lycaon pictus) are threatened by this virus. It is transmitted only when the virus is 
introduced in to bite wound or mucus membrane. The disease is incurable but preventable. In animals, 
rabies prevention is based on vaccination and the avoidance of contact with infected animals. The 
majority of animal and human exposures to rabies can be prevented by raising public awareness on 
rabies transmission routes, and avoiding contact with wildlife. Based on the above conclusions the 
following recommendations could be forwarded. 
Raising awareness of the community on the mode of transmission, prevention and control of 
rabies is of paramount importance. Use of international law to support the control of communicable 
diseases. Regulations for stray dog management should be adopted and Strict control of free-ranging dogs 
and mandatory rabies vaccination should be enforced. 
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